HomeCompareGCWOF vs MRK

GCWOF vs MRK: Dividend Comparison 2026

GCWOF yields 0.86% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GCWOF wins by $2.76M in total portfolio value· pulled ahead in Year 5
10 years
GCWOF
GCWOF
● Live price
0.86%
Share price
$10.47
Annual div
$0.09
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.81M
Annual income
$2,300,691.30
Full GCWOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GCWOF vs MRK

📍 GCWOF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGCWOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GCWOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GCWOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GCWOF
Annual income on $10K today (after 15% tax)
$73.15/yr
After 10yr DRIP, annual income (after tax)
$1,955,587.60/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GCWOF beats the other by $1,947,259.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GCWOF + MRK for your $10,000?

GCWOF: 50%MRK: 50%
100% MRK50/50100% GCWOF
Portfolio after 10yr
$1.44M
Annual income
$1,155,244.72/yr
Blended yield
80.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GCWOF
No analyst data
Altman Z
3.7
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GCWOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGCWOFMRK
Forward yield0.86%2.76%
Annual dividend / share$0.09$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$2.81M$56.8K
Annual income after 10y$2,300,691.30$9,798.13
Total dividends collected$2.75M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GCWOF vs MRK ($10,000, DRIP)

YearGCWOF PortfolioGCWOF Income/yrMRK PortfolioMRK Income/yrGap
1$10,872$172.11$11,206$366.19$334.00MRK
2$11,983$349.76$12,650$502.35$667.00MRK
3$13,542$720.55$14,407$694.19$865.00MRK
4$16,012$1,522.08$16,585$967.82$573.00MRK
5← crossover$20,497$3,363.93$19,342$1,363.89+$1.2KGCWOF
6$29,981$8,048.81$22,913$1,947.19+$7.1KGCWOF
7$54,085$22,005.30$27,662$2,823.89+$26.4KGCWOF
8$132,071$74,200.31$34,159$4,173.35+$97.9KGCWOF
9$479,992$338,676.45$43,337$6,308.80+$436.7KGCWOF
10$2,814,283$2,300,691.30$56,776$9,798.13+$2.76MGCWOF

GCWOF vs MRK: Complete Analysis 2026

GCWOFStock

GCC, S.A.B. de C.V., through its subsidiaries, produces, distributes, and sells gray Portland cement, ready-mix concrete, aggregates, and other building construction materials in Mexico and the United States. It offers cement; ready mix concrete, energy; building materials; and asphalt. The company also provides special products comprising Komponent, a shrinkage-compensating, expanding concrete additive; Metaforce, a reactive and consistent pozzolan that is used as an alternative for fly ash; Microsilex to be used in bridge decks and paving; Rapid Set, a solution for concrete applications; and Versabind, a cementitious that is used as filler in asphalt mixes as a replacement for lime. It distributes its products through distribution centers and independent wholesale distributors. The company was formerly known as Grupo Cementos de Chihuahua, S.A.B. de C.V. and changed its name to GCC, S.A.B. de C.V. in March 2021. GCC, S.A.B. de C.V. was founded in 1941 and is based in Chihuahua, Mexico. GCC, S.A.B. de C.V. is a subsidiary of CAMCEM, S.A. de C.V.

Full GCWOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GCWOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GCWOF vs SCHDGCWOF vs JEPIGCWOF vs OGCWOF vs KOGCWOF vs MAINGCWOF vs JNJGCWOF vs ABBVGCWOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.